Showing 541 - 560 results of 743 for search '"chronic kidney disease"', query time: 0.07s Refine Results
  1. 541

    The influence of the pharmacodynamic properties of drugs on indications for their use: Sodium-glucose cotransporter 2 inhibitors (SGLT2 inhibitors) by Denda Nikola I., Maletin Nemanja Z., Atanasković Marko B., Vučković Biljana A., Rašković Aleksandar L.

    Published 2024-01-01
    “…Methods: A thorough review of literature from 2000 to 2023 via PubMed focused on SGLT2 inhibitors' pharmacology and clinical impact on T2DM, heart failure, and chronic kidney disease. Twenty relevant studies were analyzed to understand differences between these inhibitors, refining their efficacy and safety profiles. …”
    Get full text
    Article
  2. 542

    Development and validation of a clinical prediction model of acute kidney injury in intensive care unit patients at a rural tertiary teaching hospital in South Africa: a study prot... by Olanrewaju Oladimeji, Constance Sewani-Rusike, Busisiwe Mrara, Fathima Paruk

    Published 2022-07-01
    “…With the only therapeutic option being supportive therapy, prevention and early diagnosis will facilitate timely interventions to prevent progression to chronic kidney disease. While many factors have been identified as predictive of AKI, none have shown adequate sensitivity or specificity on their own. …”
    Get full text
    Article
  3. 543

    Glomerular Filtration Result in Patients with Hypertensive Emergencies by Manuel Tasis Hernández, Wendy Talavera Hernández, Valentina Edighill Villanueva, Aliucha María Rodríguez Díaz, Taimy Calvera Castro, Juan Francisco Gastón Del Monte

    Published 2020-06-01
    “…<strong>Foundation</strong>: hypertensive emergencies may be the presentation of an underlying chronic kidney disease; in turn kidney damage may be the cause that leads to hypertensive emergency. …”
    Get full text
    Article
  4. 544

    Characteristics and Clinical Course of Patients with Acute Myocardial Infarction and ST-segment Elevation with and without Interatrial Block by Francisco de Jesús Valladares Carvajal, Verónica Mercedes Carretero Acosta, Raimundo Carmona Puerta, Aymara Marcia Hernández Cardoso, Ernesto Julio Bernal Valladares

    Published 2023-08-01
    “…Demographic variables were analyzed: age, sex, skin color and between clinics: toxic habits; (smoker, ex-smoker); medical history (myocardial infarction, angina, peripheral arterial disease, arterial hypertension, type 2 diabetes mellitus, chronic kidney disease; infarct location (anterior, inferior, left bundle branch block); complications: heart failure, atrial fibrillation, ventricular tachycardia/ventricular fibrillation, atrioventricular conduction disorders, mechanical complication, post infarction angina, arterial embolism) and discharge status (alive or deceased). …”
    Get full text
    Article
  5. 545

    Cost-Effectiveness Analysis for the Treatment of Hyperphosphatemia in Predialysis Patients: Calcium-Based versus Noncalcium-Based Phosphate Binders by B. L. Goh, A. Soraya, A. Goh, K. L. Ang

    Published 2018-01-01
    “…Hyperphosphatemia in chronic kidney disease (CKD) patients is often treated with calcium carbonate (CaCO3) despite the fact that CaCO3 is associated with increased calcium load and potentially increased cardiovascular risk. …”
    Get full text
    Article
  6. 546

    Cystatin C Levels in Middle-Aged Patients with Obstructive Sleep Apnea Syndrome by Kostas Archontogeorgis, Evangelia Nena, Christina Tsigalou, Athanasios Voulgaris, Maria Xanthoudaki, Marios Froudarakis, Paschalis Steiropoulos

    Published 2016-01-01
    “…Obstructive sleep apnea syndrome (OSAS) is associated with systemic inflammation and increased risk of cardiovascular and chronic kidney disease. Cystatin C (Cyst C) is a novel biomarker of both latent renal damage and cardiovascular disease. …”
    Get full text
    Article
  7. 547

    Osteoprotegerin as an Emerging Biomarker of Carotid Artery Stenosis? A Scoping Review with Meta-Analysis by Jerzy Chudek, Marta Pośpiech, Anna Chudek, Michał Holecki, Monika Puzianowska-Kuźnicka

    Published 2025-01-01
    “…In addition, chronic kidney disease, the most significant confounder disturbing the association between vascular damage and circulating OPG levels, decreases the usefulness of OPG as a BM in CAS. …”
    Get full text
    Article
  8. 548

    Renal Dysfunction, Metabolic Syndrome and Cardiovascular Disease Mortality by David Martins, Chizobam Ani, Deyu Pan, Omolola Ogunyemi, Keith Norris

    Published 2010-01-01
    “…Renal disease is commonly described as a complication of metabolic syndrome (MetS) but some recent studies suggest that Chronic Kidney disease (CKD) may actually antecede MetS. Few studies have explored the predictive utility of co-clustering CKD with MetS for cardiovascular disease (CVD) mortality. …”
    Get full text
    Article
  9. 549

    The Relation of Coffee Consumption to Serum Uric Acid in Japanese Men and Women Aged 49–76 Years by Ngoc Minh Pham, Daigo Yoshida, Makiko Morita, Guang Yin, Kengo Toyomura, Keizo Ohnaka, Ryoichi Takayanagi, Suminori Kono

    Published 2010-01-01
    “…Study subjects were derived from the baseline survey of a cohort study on lifestyle-related diseases, and included 11.662 men and women aged 49–76 years; excluded were those with medication for gout and hyperuricemia, use of diuretic drugs, and medical care for cancer or chronic kidney disease. Statistical adjustment was made for body mass index, alcohol use, hypertension, diabetes mellitus, and other factors. …”
    Get full text
    Article
  10. 550

    Healthcare Resource Utilization and Costs Associated with Autosomal Dominant Polycystic Kidney Disease by Christopher M. Blanchette, Şerban R. Iorga, Aylin Altan, Jerry G. Seare, Ying Fan, Sandro Rossetti, Benjamin Gutierrez

    Published 2014-07-01
    “…**Objectives:** The objective of this study was to assess real-world healthcare resource utilization and cost among commercially insured (COM) and Medicare Advantage (MAPD) ADPKD patients in addition to the cost profile by chronic kidney disease (CKD) stage. **Methods:** Patients diagnosed with ADPKD (two or more claims) with ≥30 days of continuous medical and pharmacy benefits and no evidence of autosomal recessive polycystic kidney disease were selected (Optum Research Database and Impact National Benchmarking Database: 1/1/06–8/31/12). …”
    Get full text
    Article
  11. 551

    Renal Function and Ultrasound Imaging in Elderly Subjects by Luca Zanoli, Giulia Romano, Marcello Romano, Stefania Rastelli, Francesco Rapisarda, Antonio Granata, Pasquale Fatuzzo, Mariano Malaguarnera, Pietro Castellino

    Published 2014-01-01
    “…We evaluated in elderly subjects (a) the ability of GFR formulas to discriminate chronic kidney disease (CKD), (b) the correlation between renal morphology and function, and (c) the usefulness of combined r-US and GFR formulas to detect CKD. …”
    Get full text
    Article
  12. 552

    Angiographic and Clinical Impact of Novel Revascularization for Occluded Femoropopliteal Prosthetic Bypass Graft: A Combination of Surgical Thrombectomy and Drug-Coated Balloon Ang... by Tatsuro Takei, Takashi Kajiya, Keisuke Yamamoto, Junichiro Takaoka, Yoshihiko Atsuchi, Nobuhiko Atsuchi

    Published 2023-01-01
    “…A 77-year-old man with a history of chronic kidney disease and coronary artery disease presented to our clinic with rest pain on his left leg. …”
    Get full text
    Article
  13. 553

    Oxidative stress and inflammation in hemodialysis: a comparison of patients with or without advanced nonalcoholic fatty liver disease (NAFLD) by Vanja Kalacun, Robert Ekart, Sebastjan Bevc, Pavel Skok, Radovan Hojs, Nina Vodošek Hojs

    Published 2025-12-01
    “…Nonalcoholic fatty liver disease (NAFLD) and chronic kidney disease are global public health issues associated with high morbidity and mortality. …”
    Get full text
    Article
  14. 554

    Black Garlic Supplementation and Glomerular Protection in Hyperuricemic Rats: A Study on Kidney Health Prevention by Wahyudin Wahyudin, Fajar Wahyu Pribadi, Gita Nawangtantrini, Muhammad Riski Fatah, Zainuddin Zainuddin

    Published 2024-11-01
    “…Introduction: Hyperuricemia is a significant risk factor for the development of chronic kidney disease. Excessive uric acid can deposit in the kidneys, triggering inflammatory reactions and oxidative stress, leading to structural damage in the glomeruli. …”
    Get full text
    Article
  15. 555

    High-resolution mass spectrometry measurement of N-terminal carbamylated hemoglobin as a potential marker for chronic diseases with elevated blood urea levels by Fangjun Chen, Priscilla S.-W. Yeung, Carolyn V. Wong, Ruben Y. Luo

    Published 2025-01-01
    “…Introduction: N-terminal carbamylated hemoglobin (CarHb) reflects long-term blood urea levels and has potential as a marker for chronic kidney disease (CKD) and other chronic conditions with elevated blood urea levels. …”
    Get full text
    Article
  16. 556

    The socioeconomic impact of kidney disease on African families: a scoping review by Ikponmwosa Jude Ogieuhi, Nicholas Aderinto, Gbolahan Olatunji, Emmanuel Kokori, Victor Oluwatomiwa Ajekiigbe, Komolafe Babajide Ayodeji, Adetola Emmanuel Babalola, Ifeanyichukwu Muogbo, Alabi Badrudeen Olalekan, Aarushi Venkatraman, Oluwaseun Oyewo

    Published 2025-01-01
    “…This review highlighted that the socioeconomic status of a patient is inversely related to chronic kidney failure (CKF). Both chronic kidney disease (CKD) and its treatment are financially demanding for patients. …”
    Get full text
    Article
  17. 557

    The link between hyperuricemia and diabetes: insights from a quantitative analysis of scientific literature by Lili Ma, Jing Wang, Li Ma, Xian Min Wang

    Published 2025-02-01
    “…The reference network from 1987 to September 30, 2024, identified 19 clusters highlighting key research areas in HUA and diabetes, such as metabolic syndrome, uropathology, chronic kidney disease (CKD), and CVD. Exploring pathological mechanisms and pharmacological interventions linked to diabetes concomitant with HUA has emerged as a focal point of research and a burgeoning trend within the field.ConclusionThis study is the first scientometric analysis to synthesize research trends on HUA and diabetes, revealing molecular mechanisms and treatment strategies and providing theoretical insights for future clinical use.…”
    Get full text
    Article
  18. 558

    Assessing the quality of CKD care using process quality indicators: A scoping review. by Na Zhou, Chengchuan Chen, Yubei Liu, Zhaolan Yu, Aminu K Bello, Yanhua Chen, Ping Liu

    Published 2024-01-01
    “…<h4>Introduction</h4>Assessing the quality of chronic kidney disease (CKD) management is crucial for optimal care and identifying care gaps. …”
    Get full text
    Article
  19. 559
  20. 560

    Risk Factors and Consequent Diseases of Atherosclerosis in a Population Treated in a Medical Office by Luis Ángel Felicó Riverón, Georgia Díaz-Perera Fernández, Yomeidis Felicó Riverón

    Published 2024-11-01
    “…Altered waist circumference has the highest risk associated with peripheral arterial disease; high blood pressure with cardiovascular disease and peripheral arterial disease; and diabetes and dyslipidemia with chronic kidney disease.<br /> <strong>Conclusions</strong>: the diagnosis of high blood pressure and cardiovascular diseases predominated. …”
    Get full text
    Article